real-time news and commentary for investors
Wednesday, Dec 12
2012, 12:13 PM
Sucampo Pharmaceuticals (SCMP +4.2%) moves higher today after earlier announcing its...
Sucampo Pharmaceuticals (SCMP +4.2%) moves higher today after earlier announcing its supplemental new drug application for Rescula, a treatment for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, has been approved by the FDA. According to the labeling, the treatment may be used as a first-line agent or in tandem with other topical ophthalmic drugs.